Cannara Biotech, Inc. (LOVE.V)
1.86
-0.02
(-1.06%)
CAD |
TSXV |
Feb 11, 16:00
Cannara Biotech Total Assets (Quarterly) : 173.84M for Nov. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Medexus Pharmaceuticals, Inc. | 207.93M |
| Theralase Technologies, Inc. | 3.004M |
| Cronos Group, Inc. | 1.640B |
| Auxly Cannabis Group, Inc. | 276.43M |
| Organigram Global, Inc. | 530.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 62.63M |
| Shareholders Equity (Quarterly) | 111.21M |
| Debt to Equity Ratio | 0.3129 |
| Current Ratio | 2.700 |
| Net Debt Paydown Yield | 1.69% |